CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study)
- 1 June 1995
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 71 (6) , 1283-1287
- https://doi.org/10.1038/bjc.1995.248
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Alternating Non-Cross-Resistant Combination Chemotherapy or MOPP in Stage IV Hodgkin's DiseaseAnnals of Internal Medicine, 1986
- The Norton-Simon hypothesis revisited.1986
- A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer.Journal of Clinical Oncology, 1985
- The importance of dose intensity in chemotherapy of metastatic breast cancer.Journal of Clinical Oncology, 1984
- Randomized trial of cyclophosphamide, doxorubicin, and 5-fluorouracil alone or alternating with a "cycle active" non-cross-resistant combination in women with visceral metastatic breast cancer: a Southeastern Cancer Study Group project.Journal of Clinical Oncology, 1984
- Prospective evaluation of rotating chemotherapy in advanced breast cancer. An Eastern Cooperative Oncology Group Trial.1983
- Comparison of induction chemotherapies for metastatic breast cancer. An eastern cooperative oncology group trialCancer, 1982
- Combination chemotherapy for advanced breast cancer.Two regimens containing adriamycinCancer, 1978
- Combination Chemotherapy as an Adjuvant Treatment in Operable Breast CancerNew England Journal of Medicine, 1976
- Evaluation of survival data and two new rank order statistics arising in its consideration.1966